Literature DB >> 2452189

Frequency and epitope recognition of anti-ribosome P antibodies from humans with systemic lupus erythematosus and MRL/lpr mice are similar.

E Bonfa1, A Marshak-Rothstein, H Weissbach, N Brot, K Elkon.   

Abstract

Autoantibodies reactive against a shared, conserved epitope on the ribosomal phosphoproteins P0, P1, and P2 occur in approximately 15% of patients with SLE and are relatively specific for this disease. To determine whether anti-P antibodies occur in murine lupus, serum from MRL/lpr and NZB/W F1 mice were analyzed by immunoblotting as well as by ELISA using a synthetic peptide Ag. Of those analyzed, 4 of 35 (11%) MRL/lpr, 0 of 25 NZB/W F1 and 0 of 13 control NIH/Swiss mice had anti-P antibodies. Anti-P specificity was confirmed by immunoblotting of ribosomal proteins separated by two-dimensional gel electrophoresis and by inhibition of anti-P reactivity on immunoblots with the synthetic peptide Ag. These findings indicate a striking similarity in the frequency and fine epitope specificity of anti-P antibodies in humans and MRL/lpr mice with SLE.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452189

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  IgG anti-cardiolipin antibodies in murine lupus.

Authors:  A E Gharavi; R C Mellors; K B Elkon
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

2.  Characterization of anti-P monoclonal antibodies directed against the ribosomal protein-RNA complex antigen and produced using Murphy Roths large autoimmune-prone mice.

Authors:  H Sato; M Onozuka; A Hagiya; S Hoshino; I Narita; T Uchiumi
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

3.  Organelles do not colocalize with mRNA granules in post-ischemic neurons.

Authors:  J T Jamison; J J Szymanski; D J Degracia
Journal:  Neuroscience       Date:  2011-09-19       Impact factor: 3.590

4.  mRNA redistribution during permanent focal cerebral ischemia.

Authors:  Monique K Lewis; Jill T Jamison; Joseph C Dunbar; Donald J DeGracia
Journal:  Transl Stroke Res       Date:  2013-08-06       Impact factor: 6.829

5.  TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus.

Authors:  Kevin M Nickerson; Sean R Christensen; Jonathan Shupe; Michael Kashgarian; Daniel Kim; Keith Elkon; Mark J Shlomchik
Journal:  J Immunol       Date:  2010-01-20       Impact factor: 5.422

6.  MRL/lpr-->severe combined immunodeficiency mouse allografts produce autoantibodies, acute graft-versus-host disease or a wasting syndrome depending on the source of cells.

Authors:  D Ashany; J J Hines; A E Gharavi; J Mouradian; J Drappa; K B Elkon
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

7.  Quantification of lupus anti-ribosome P antibodies using a recombinant P2 fusion protein and determination of the predicted amino acid sequence of the autoantigen in patients' mononuclear cells.

Authors:  J Magsaam; A E Gharavi; A P Parnassa; H Weissbach; N Brot; K B Elkon
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

8.  Depression is an early disease manifestation in lupus-prone MRL/lpr mice.

Authors:  Hua-Xin Gao; Sean R Campbell; Min-Hui Cui; Pu Zong; Jong Hee-Hwang; Maria Gulinello; Chaim Putterman
Journal:  J Neuroimmunol       Date:  2009-01-03       Impact factor: 3.478

Review 9.  Use of synthetic peptides for the detection and quantification of autoantibodies.

Authors:  K B Elkon
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

10.  Fine specificities of anti-nuclear antibodies in murine models of graft-versus-host disease.

Authors:  A P van Dam; J F Meilof; H G van den Brink; R J Smeenk
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.